From the Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, Cambridge, United Kingdom (A.T., H.Y., M.A.-J., M.R.B., S.S.); and Division of Biopharmaceutics, Leiden/Amsterdam Centre for Drug Research, Leiden University, Einsteinweg, Leiden, The Netherlands (M.R.B., T.v.B., I.B.).
Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2355-65. doi: 10.1161/ATVBAHA.112.301000. Epub 2013 Jul 3.
Myocardin, a potent transcriptional coactivator of serum response factor, is involved in vascular development and promotes a contractile smooth muscle phenotype. Myocardin levels are reduced during vascular injury, in association with phenotypic switching of smooth muscle cells (SMCs). However, the direct role of myocardin in vascular disease is unclear.
We show that re-expression of myocardin prevents the vascular injury response in murine carotid arteries, with reduced neointima formation due to decreased SMC migration and proliferation. Myocardin reduced SMC migration by downregulating platelet-derived growth factor receptor-β (PDGFRB) expression. Pdgfrb was regulated by myocardin-induced miR-24 and miR-29a expression, and antagonizing these microRNAs restored SMC migration. Furthermore, using miR-24 and miR-29a mimics, we demonstrated that miR-29a directly regulates Pdgfrb expression at the 3' untranslated region while miR-24 has an indirect effect on Pdgfrb levels. Myocardin heterozygous-null mice showed an augmented neointima formation with increased SMC migration and proliferation, demonstrating that endogenous levels of myocardin are a critical regulator of vessel injury responses.
Our results extend the function of myocardin from a developmental role to a pivotal regulator of SMC phenotype in response to injury, and this transcriptional coactivator may be an attractive target for novel therapeutic strategies in vascular disease.
肌球蛋白结合蛋白 C,一种血清反应因子的有效转录共激活因子,参与血管发育并促进收缩型平滑肌表型。血管损伤时肌球蛋白结合蛋白 C 的水平降低,与平滑肌细胞(SMC)的表型转换有关。然而,肌球蛋白结合蛋白 C 在血管疾病中的直接作用尚不清楚。
我们表明,心肌球蛋白的重新表达可防止小鼠颈动脉中的血管损伤反应,由于 SMC 迁移和增殖减少,导致新生内膜形成减少。肌球蛋白结合蛋白 C 通过下调血小板衍生生长因子受体-β(PDGFRB)表达来减少 SMC 迁移。Pdgfrb 受肌球蛋白结合蛋白 C 诱导的 miR-24 和 miR-29a 表达调控,拮抗这些 microRNAs 可恢复 SMC 迁移。此外,使用 miR-24 和 miR-29a 模拟物,我们证明 miR-29a 直接在 3'非翻译区调节 Pdgfrb 表达,而 miR-24 对 Pdgfrb 水平具有间接影响。心肌球蛋白杂合缺失小鼠表现出新生内膜形成增加,SMC 迁移和增殖增加,表明内源性肌球蛋白结合蛋白 C 水平是血管损伤反应的关键调节因子。
我们的结果将肌球蛋白结合蛋白 C 的功能从发育作用扩展到损伤后 SMC 表型的关键调节因子,这种转录共激活因子可能是血管疾病新治疗策略的有吸引力的靶点。